Will This News Move These Stocks? - July 10

(RTTNews) - ReShape Lifesciences Inc. (RSLS)

ReShape Lifesciences Inc. (RSLS), a company that makes medical devices to treat obesity and metabolic diseases, announced the successful implant of the first ReShape Balloon at a Boston hospital.

The FDA-approved ReShape Balloon System involves a non-surgical weight loss procedure that uses advanced balloon technology designed to take up room in the stomach to help people with a 30-40 kg/m2 Body Mass Index or BMI and at least one co-morbidity, lose weight.

Scott Shikora, Chief Medical Officer at ReShape Lifesciences, who performed the implant called the ReShape Balloon a "minimally invasive and non-anatomy altering weight loss solution."

**